EP300 and prostate carcinoma: That result was consistent with findings in other human malignancies, such as esophageal squamous carcinoma [16], prostate cancer [18], and hepatocellular cancer [17], indicating p300 playing an important role in tumor progression, although some other studies demonstrated p300 as a tumor suppressor in breast cancer [12] and gastric cancer [11].